Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rod Jackson

Showing results (171-180 of 194) with videos related to

Pageof 20
Sort By:
The New Zealand Medical Journal|June 21, 2022
Ethnic variation in the trends of new implantable cardioverter defibrillator implants in New Zealand 2005-2019 (ANZACS-QI 63)Fang Shawn Foo, Mildred Lee, Katrina K Poppe, et al.
Journal of Arrhythmia|February 20, 2020
Implantable cardioverter defibrillator and cardiac resynchronization therapy use in New Zealand (ANZACS-QI 33)Fang Shawn Foo, Mildred Lee, Khang-Li Looi, et al.
The New Zealand Medical Journal|February 15, 2011
A comparative analysis of cardiovascular disease risk profiles of five Pacific ethnic groups assessed in New Zealand primary care practice: PREDICT CVD-13Corina Grey, Sue Wells, Tania Riddell, et al.
The New Zealand Medical Journal|February 27, 2010
A comparative analysis of the cardiovascular disease risk factor profiles of Pacific peoples and Europeans living in New Zealand assessed in routine primary care: PREDICT CVD-11Corina Grey, Sue Wells, Tania Riddell, et al.
Circulation|July 1, 2004
Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke ForumSidney C Smith, Rod Jackson, Thomas A Pearson, et al.
The New Zealand Medical Journal|August 11, 2016
The All New Zealand Acute Coronary Syndrome Quality Improvement Programme: Implementation, Methodology and Cohorts (ANZACS-QI 9)Andrew Kerr, Michael Ja Williams, Harvey White, et al.
European Journal of Preventive Cardiology|October 4, 2012
Initiation and maintenance of cardiovascular medications following cardiovascular risk assessment in a large primary care cohort: PREDICT CVD-16Suneela Mehta, Sue Wells, Corina Grey, et al.
European Journal of Preventive Cardiology|September 28, 2023
Development and validation of cardiovascular risk prediction equations in 76 000 people with known cardiovascular diseaseAnders Holt, Bruno Batinica, Jingyuan Liang, et al.
Lancet (London, England)|May 9, 2018
Cardiovascular disease risk prediction equations in 400 000 primary care patients in New Zealand: a derivation and validation studyRomana Pylypchuk, Sue Wells, Andrew Kerr, et al.
Contemporary Clinical Trials|July 23, 2011
IMProving Adherence using Combination Therapy (IMPACT): design and protocol of a randomised controlled trial in primary careVanessa Selak, C Raina Elley, Sue Crengle, et al.
Pageof 20

Showing results (171-180 of 194) with videos related to

Sort By:
Pageof 20
The New Zealand Medical Journal|June 21, 2022
Ethnic variation in the trends of new implantable cardioverter defibrillator implants in New Zealand 2005-2019 (ANZACS-QI 63)Fang Shawn Foo, Mildred Lee, Katrina K Poppe, et al.
Journal of Arrhythmia|February 20, 2020
Implantable cardioverter defibrillator and cardiac resynchronization therapy use in New Zealand (ANZACS-QI 33)Fang Shawn Foo, Mildred Lee, Khang-Li Looi, et al.
The New Zealand Medical Journal|February 15, 2011
A comparative analysis of cardiovascular disease risk profiles of five Pacific ethnic groups assessed in New Zealand primary care practice: PREDICT CVD-13Corina Grey, Sue Wells, Tania Riddell, et al.
The New Zealand Medical Journal|February 27, 2010
A comparative analysis of the cardiovascular disease risk factor profiles of Pacific peoples and Europeans living in New Zealand assessed in routine primary care: PREDICT CVD-11Corina Grey, Sue Wells, Tania Riddell, et al.
Circulation|July 1, 2004
Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke ForumSidney C Smith, Rod Jackson, Thomas A Pearson, et al.
The New Zealand Medical Journal|August 11, 2016
The All New Zealand Acute Coronary Syndrome Quality Improvement Programme: Implementation, Methodology and Cohorts (ANZACS-QI 9)Andrew Kerr, Michael Ja Williams, Harvey White, et al.
European Journal of Preventive Cardiology|October 4, 2012
Initiation and maintenance of cardiovascular medications following cardiovascular risk assessment in a large primary care cohort: PREDICT CVD-16Suneela Mehta, Sue Wells, Corina Grey, et al.
European Journal of Preventive Cardiology|September 28, 2023
Development and validation of cardiovascular risk prediction equations in 76 000 people with known cardiovascular diseaseAnders Holt, Bruno Batinica, Jingyuan Liang, et al.
Lancet (London, England)|May 9, 2018
Cardiovascular disease risk prediction equations in 400 000 primary care patients in New Zealand: a derivation and validation studyRomana Pylypchuk, Sue Wells, Andrew Kerr, et al.
Contemporary Clinical Trials|July 23, 2011
IMProving Adherence using Combination Therapy (IMPACT): design and protocol of a randomised controlled trial in primary careVanessa Selak, C Raina Elley, Sue Crengle, et al.
Pageof 20